U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812702) titled 'Parkinson's Disease Biomarker Study' on Feb. 02.
Brief Summary: The primary objective of this study is to determine whether data acquired from a remote monitoring approach can reliably identify and track motor symptoms in prodromal PD and clinical PD.
The study is a one-year longitudinal biomarker study recruiting idiopathic RBD patients, Parkinson's Disease patient and healthy controls. All participants receive a smartphone with the Roche PD Mobile Application, complete a number of active tests daily and their movements will be remotely monitored. Participants will undergo additional neurological exams and DaT-SPECT and MRI imaging...